ISRCTN15045512进行中(未招募)Unknown
Varicella zoster recombinant HZ/su vaccine: immunogenicity and safety in people living with HIV according to LTCD4 count strata
niversity of Rome Tor Vergata0 个研究点目标入组 500 人开始时间: 2024年3月5日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. People living with HIV (PLWHIV) =18 years old, on antiretroviral treatment, virally suppressed (HIVRNA <50 copies/ml in the last 6 months)
- •2. Able to provide informed consent
- •3. Available CD4 cell count in the last 6 months
排除标准
- •1. Age <18 years old
- •2. Active herpes zoster episode at enrollment
- •3. Acute disease/fever at enrollment
- •4. Known allergy to vaccine component
- •5. Other than HIV immunosuppressive condition or treatment. Prednisone <20 mg/day, or equivalent, is allowed. Inhaled and topical steroids are allowed
- •6. Pregnancy
- •7. Lactation
- •8. Women planning to become pregnant or planning to discontinue contraceptive methods
研究者
相似试验
招募中
Unknown
Investigation of varicella-zoster vaccine immunogenicity according to frailty statusKCT0009555Seoul National University Bundang Hospital100
已完成
不适用
Immunity to varicella-zoster virus in immunocompromised renal disease patientsimmunosuppression by chronic renal failure/renal replacement therapy amd renal transplantation transplantation100276651004743810038430NL-OMON45220niversitair Medisch Centrum Groningen210
尚未招募
不适用
Immunogenicity of a recombinant zoster vaccine (RZV) against herpes zoster (HZ) in adults with rheumatic diseases (SECTORED)DRKS00027579St. Elisabeth Gruppe GmbH Katholische Kliniken Rhein-Ruhr150
已完成
2 期
Evaluation of varicella zoster virus specific immune response after varicella vaccine immunization in elderly patients with diabetes mellitus.diabetes mellitusJPRN-UMIN000004771Kitano hospital, The Tazuke Kofukai Medical Research Institute50
已完成
1 期
Evaluation of Varicella Zoster Virus specific immune response assessed by IFN-g releasing assayhealthy adult, 20 to 75 years of ageJPRN-UMIN000018695The Tazuke Kofukai Medical Research Institute17
